Apolipoprotein A1; Apolipoprotein B; C-Reactive Protein; Cholesterol; HDL; Homocysteine; LDL; Lipoprotein (a); Non-HDL Cholesterol; Oxidized LDL; PLAC (LP-PLA2 Activity); Triglycerides; small dense LDL; vLDL
Back to Test Catalogue
Cardiac Risk Profile, Serum
Test ID: CARDRISK
Test
Method
EIA
Report Includes
Specimens
Serum
Clinical Utility
Cardiovascular disease (CVD) is associated with more deaths than all cancersand more deaths in women than breast cancer. This Cardiovascular Risk Profile evaluates a thorough battery of traditional and advanced biomarkers to aid in early detection and modification of risk factors. Doctor’s Data measures oxidized LDL, small dense LDL and Lp(a), which are higher in CVD patients and correlated with the severity of CVD. A total of 11 primary and secondary risk factors are evaluated to provide actionable information.
Source: https://www.doctorsdata.com/cardiovascular-risk-profile/;Accessed 21-Oct-2016
Test Location
Doctor's Data, IL, USA
Test Version
9-May-2022
Specimen
Specimens
Serum
Sample Volume
2 mL
Minimum Volume
1 mL
Additional Information
A specimen collection kit is available. To order a kit online, please register or login. For assistance or more information, please click here to send us an email or call 416-422-3000 x 300.
For additional information refer to the Doctors Data websiteCardiovascular Risk Profile
Stability
| Ambient | 7 Days |
|---|---|
| Refrigerated | 14 Days |
| Frozen | 30 Days |
Rejection Criteria
| Hemolysis | Present |
|---|
Test Version
9-May-2022
Performance / Interpretation
Method
EIA
Turnaround Time
7 Days
Sample Reports
Sample Report at external website.
Test Location
Doctor's Data, IL, USA
Test Version
9-May-2022